Clarify New Guidelines for Prevnar 20 and Vaxneuvance
March 2022
You’ll need to know which adults should get one of the new pneumococcal vaccines, Prevnar 20 or 15-valent Vaxneuvance...and when.
These conjugate vaccines may lead to longer-lasting and better immunity than Pneumovax 23 polysaccharide vaccine. CDC projects the new vaccines will reduce overall pneumococcal disease and healthcare costs.
This is leading to changes in pneumococcal guidelines for adults 65 and up...or 19 to 64 with risk factors (cancer, diabetes, smoking, etc).
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote